Quoin Pharmaceuticals Stock (NASDAQ:QNRX)
Previous Close
$0.31
52W Range
$0.28 - $6.18
50D Avg
$0.57
200D Avg
$0.63
Market Cap
$1.62M
Avg Vol (3M)
$3.50M
Beta
1.89
Div Yield
-
QNRX Company Profile
Quoin Pharmaceuticals, Ltd., a specialty pharmaceutical company, focuses on the development of therapeutic products for rare and orphan diseases. The company's lead product is QRX003, a topical lotion to treat Netherton Syndrome. It also develops QRX004 for the treatment dystrophic epidermolysis bullosa; and QRX006, a therapy to treat rare skin disease. The company is based in Ashburn, Virginia.